Pharmacia's Tooman Named Head of IR at ILEX
Charting the future of public relations
Holmes Report
CEO

Pharmacia's Tooman Named Head of IR at ILEX

Craig Tooman, who led an award-winning investor relations practice at Pharmacia, has joined ILEX Oncology, an oncology drug development company, as vice president of investor relations.

Paul Holmes

SAN ANTONIO, March 14—Craig Tooman, who led an award-winning investor relations practice at Pharmacia, has joined ILEX Oncology, an oncology drug development company, as vice president of investor relations. He will report to president and chief executive officer, Jeff Buchalter.
 
Tooman has more than 14 years of pharmaceutical experience, having worked extensively in positions including investor relations, strategic planning, finance, marketing and sales. He has also held positions in Europe and Japan. At ILEX, he will be responsible for all investor and shareholder services, coordinating communication with the investor community and ILEX shareholders.
 
At Pharmacia, Tooman most recently held the position of vice president of investor relations and spearheaded communications with the investment community on the Pharmacia & Upjohn/Monsanto merger.
View Style:

Load 3 More
comments powered by Disqus